Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects

NCT02392702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: C-10355
DRUG: C-10358
DRUG: Kalydeco

Sponsor

Concert Pharmaceuticals